HIGHLIGHTS
- who: Ellagic acid Anti-angiogenesis and collaborators from the School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Estates Building, Sassoon Road, Hong Kong, China have published the paper: Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer, in the Journal: (JOURNAL)
- how: The results showed that ellagic acid administration did not result in LDH release from endothelial cells indicating that ellagic acid posed little cytotoxicity effects upon HUVECs (values represent means ± SD n=6). e VEGF-induced HUVECs were treated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.